Guided Therapeutics, Inc. (OTCMKTS:GTHP – Get Free Report)’s stock price fell 1.5% on Thursday . The stock traded as low as $0.14 and last traded at $0.14. 813 shares changed hands during trading, a decline of 92% from the average session volume of 10,628 shares. The stock had previously closed at $0.15.
Guided Therapeutics Stock Performance
The business’s 50-day simple moving average is $0.17 and its 200-day simple moving average is $0.15. The company has a market capitalization of $9.30 million, a price-to-earnings ratio of -4.76 and a beta of 0.58.
About Guided Therapeutics
Guided Therapeutics, Inc, a medical technology company, focuses on developing medical devices. It focuses on the commercialization of LuViva, a non-invasive cervical cancer detection device that identifies cervical cancers and precancers painlessly, non-invasively, and at the point-of-care by scanning the cervix with light, then analyzing the light reflected and fluorescent light.
Featured Stories
- Five stocks we like better than Guided Therapeutics
- What is a Stock Market Index and How Do You Use Them?
- MercadoLibre: Latin America’s Digital Titan Just Got Cheaper
- What is an Earnings Surprise?
- Breaking Down Pegasystems, A Wedbush Top AI Pick for 2025
- What is the Nasdaq? Complete Overview with History
- Shutterstock and Getty: A $3.7 Billion Visual Content Giant
Receive News & Ratings for Guided Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Guided Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
